| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Pubmed | PSAT1 OFD1 SUN1 RALGAPB LETM1 TAB3 NCOR2 PPP2R3A MTMR7 UBA1 PHLPP1 STIP1 CDC25A YME1L1 KDM6A NOTCH1 | 5.48e-07 | 1049 | 118 | 16 | 27880917 | |
| Pubmed | Activity-based E3 ligase profiling uncovers an E3 ligase with esterification activity. | 9.12e-07 | 95 | 118 | 6 | 29643511 | |
| Pubmed | MYLK DNAH2 PLXNB2 LRP1B MTMR7 UBA1 LATS1 HECW2 PRMT1 PLCB3 PLCL1 CDC25A KCNH5 | 1.27e-06 | 730 | 118 | 13 | 34857952 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 5.38e-06 | 475 | 118 | 10 | 31040226 | |
| Pubmed | Physiological and pathophysiological characteristics of ataxin-3 isoforms. | 5.58e-06 | 281 | 118 | 8 | 30455355 | |
| Pubmed | CEP85L POLG TTLL5 NCAPH2 LRP1B SATB1 SACS RTRAF DAAM2 YY1AP1 CHD6 ZNF84 CTSL YME1L1 KDM6A SOS1 | 7.41e-06 | 1285 | 118 | 16 | 35914814 | |
| Pubmed | SLC12A6 MYH9 MYLK DNAH2 APOB PABPC5 NEB LETM1 RYR2 NUP54 LATS1 SACS ETHE1 ITSN2 CHD6 ZNF84 HSPA1L | 7.66e-06 | 1442 | 118 | 17 | 35575683 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | OFD1 PSMB1 NCAPH2 CCDC122 RSPRY1 EHD3 UBA1 TMEM120A DDHD1 PRMT1 HSPA1L MUC5AC YME1L1 NUP160 INVS DNPEP | 1.04e-05 | 1321 | 118 | 16 | 27173435 |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 2474826 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 29150444 | ||
| Pubmed | Long-term bezafibrate treatment improves skin and spleen phenotypes of the mtDNA mutator mouse. | 1.14e-05 | 2 | 118 | 2 | 22962610 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 1577740 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 8661066 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 22965987 | ||
| Pubmed | Crosstalk between TLR4 and Notch1 signaling in the IgA nephropathy during inflammatory response. | 1.14e-05 | 2 | 118 | 2 | 29230705 | |
| Pubmed | Exome sequencing: an efficient diagnostic tool for complex neurodegenerative disorders. | 1.14e-05 | 2 | 118 | 2 | 23043354 | |
| Pubmed | ARF1 and ARF3 are required for the integrity of recycling endosomes and the recycling pathway. | 1.14e-05 | 2 | 118 | 2 | 22971977 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | UBA5 PSAT1 MYH9 NAA15 PSMB1 GBP1 RABL6 UBA1 RTRAF PRMT1 PLCB3 STIP1 HSPA1L STK24 NUP160 DNPEP | 3.38e-05 | 1455 | 118 | 16 | 22863883 |
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 21622856 | ||
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 28153611 | ||
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 23783033 | ||
| Pubmed | Hyperphosphorylation and association with RBP of the intracellular domain of Notch1. | 3.42e-05 | 3 | 118 | 2 | 11511084 | |
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 29157665 | ||
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 33155207 | ||
| Pubmed | Stabilin receptors clear LPS and control systemic inflammation. | 3.42e-05 | 3 | 118 | 2 | 34816100 | |
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 26330566 | ||
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 9842715 | ||
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 28600728 | ||
| Pubmed | Interaction of the PDZ domain of human PICK1 with class I ADP-ribosylation factors. | 3.42e-05 | 3 | 118 | 2 | 10623590 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | OFD1 CEP85L TTLL5 LRP1B TAB3 ARF1 ARF3 PPP2R3A LATS1 ITSN2 NFKBIE CLEC16A | 3.48e-05 | 853 | 118 | 12 | 28718761 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | MYH9 DOCK11 DNAH2 TIGD4 ICE1 CPT1B MYO15B HECW2 PLCB3 STIP1 CHD6 | 4.36e-05 | 736 | 118 | 11 | 29676528 |
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | 4.39e-05 | 607 | 118 | 10 | 39147351 | |
| Pubmed | ARF3 STAC2 PPP2R3A UBA1 SACS SECISBP2 PRMT1 YY1AP1 CHD6 NOTCH1 | 4.45e-05 | 608 | 118 | 10 | 16713569 | |
| Pubmed | 6.64e-05 | 638 | 118 | 10 | 31182584 | ||
| Pubmed | Targeted protein unfolding uncovers a Golgi-specific transcriptional stress response. | 6.82e-05 | 4 | 118 | 2 | 29851555 | |
| Pubmed | Wnt5a controls Notch1 signaling through CaMKII-mediated degradation of the SMRT corepressor protein. | 6.82e-05 | 4 | 118 | 2 | 22888005 | |
| Pubmed | Hyaluronan synthase 2-mediated hyaluronan production mediates Notch1 activation and liver fibrosis. | 6.82e-05 | 4 | 118 | 2 | 31189722 | |
| Pubmed | 6.82e-05 | 4 | 118 | 2 | 10713164 | ||
| Pubmed | 6.82e-05 | 4 | 118 | 2 | 7822029 | ||
| Pubmed | 6.82e-05 | 4 | 118 | 2 | 29702280 | ||
| Pubmed | 6.82e-05 | 4 | 118 | 2 | 11226752 | ||
| Pubmed | Notch signaling is activated by TLR stimulation and regulates macrophage functions. | 6.82e-05 | 4 | 118 | 2 | 18085664 | |
| Pubmed | Transcriptional integration of TLR2 and TLR4 signaling at the NCoR derepression checkpoint. | 6.82e-05 | 4 | 118 | 2 | 19595715 | |
| Pubmed | 6.82e-05 | 4 | 118 | 2 | 12482578 | ||
| Pubmed | NAA15 RALGAPB LETM1 RSPRY1 UPF2 DDHD1 ANKIB1 YY1AP1 PLCB3 CLEC16A | 7.75e-05 | 650 | 118 | 10 | 38777146 | |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | PSAT1 MYH9 RALGAPB NCAPH2 CCDC122 PLXNB2 HECW2 DDHD1 SECISBP2 PRMT1 DAAM2 TRAM2 XKRX DNPEP | 8.39e-05 | 1242 | 118 | 14 | 30973865 |
| Pubmed | Blood pressure is regulated by an alpha1D-adrenergic receptor/dystrophin signalosome. | 1.05e-04 | 27 | 118 | 3 | 18468998 | |
| Pubmed | 1.13e-04 | 5 | 118 | 2 | 9038142 | ||
| Pubmed | 1.13e-04 | 5 | 118 | 2 | 37108544 | ||
| Pubmed | 1.13e-04 | 5 | 118 | 2 | 17237423 | ||
| Pubmed | 1.13e-04 | 5 | 118 | 2 | 28040436 | ||
| Pubmed | UTX-guided neural crest function underlies craniofacial features of Kabuki syndrome. | 1.13e-04 | 5 | 118 | 2 | 29073101 | |
| Pubmed | ADP-ribosylation factor is functionally and physically associated with the Golgi complex. | 1.13e-04 | 5 | 118 | 2 | 2105501 | |
| Pubmed | Ataxin-1 and Brother of ataxin-1 are components of the Notch signalling pathway. | 1.13e-04 | 5 | 118 | 2 | 21475249 | |
| Pubmed | Telokin expression is restricted to smooth muscle tissues during mouse development. | 1.13e-04 | 5 | 118 | 2 | 11121372 | |
| Pubmed | 1.16e-04 | 552 | 118 | 9 | 36293380 | ||
| Pubmed | 1.47e-04 | 446 | 118 | 8 | 24255178 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | SLC12A6 PSAT1 POLG RALGAPB EHD3 NCOR2 PPP2R3A ANKIB1 CHD6 ZNF84 ZDHHC13 CLEC16A SCARA3 KDM6A INVS | 1.60e-04 | 1489 | 118 | 15 | 28611215 |
| Pubmed | 1.70e-04 | 6 | 118 | 2 | 34429451 | ||
| Pubmed | 1.70e-04 | 6 | 118 | 2 | 11404076 | ||
| Pubmed | 1.70e-04 | 6 | 118 | 2 | 12036294 | ||
| Pubmed | 1.70e-04 | 151 | 118 | 5 | 17043677 | ||
| Pubmed | 1.81e-04 | 153 | 118 | 5 | 10718198 | ||
| Pubmed | 2.37e-04 | 7 | 118 | 2 | 30720883 | ||
| Pubmed | 2.37e-04 | 7 | 118 | 2 | 11950392 | ||
| Pubmed | 2.63e-04 | 486 | 118 | 8 | 20936779 | ||
| Pubmed | 2.95e-04 | 38 | 118 | 3 | 29799838 | ||
| Pubmed | 3.13e-04 | 377 | 118 | 7 | 25147182 | ||
| Pubmed | 3.15e-04 | 8 | 118 | 2 | 8947846 | ||
| Pubmed | Serum Amyloid A-Mediated Inflammasome Activation of Microglial Cells in Cerebral Ischemia. | 3.15e-04 | 8 | 118 | 2 | 31611307 | |
| Pubmed | Sequencing analysis of forty-eight human image cDNA clones similar to Drosophila mutant protein. | 3.15e-04 | 8 | 118 | 2 | 10524757 | |
| Pubmed | 3.15e-04 | 8 | 118 | 2 | 18782768 | ||
| Pubmed | Loss of cell adhesion causes hydrocephalus in nonmuscle myosin II-B-ablated and mutated mice. | 3.15e-04 | 8 | 118 | 2 | 17429076 | |
| Pubmed | Expression analysis of type I ARF small GTPases ARF1-3 during mouse brain development. | 3.15e-04 | 8 | 118 | 2 | 38227057 | |
| Pubmed | 3.15e-04 | 8 | 118 | 2 | 8195219 | ||
| Pubmed | Mammalian Staufen1 recruits Upf1 to specific mRNA 3'UTRs so as to elicit mRNA decay. | 3.15e-04 | 8 | 118 | 2 | 15680326 | |
| Pubmed | 3.15e-04 | 8 | 118 | 2 | 25825216 | ||
| Pubmed | Asparagine endopeptidase controls anti-influenza virus immune responses through TLR7 activation. | 3.15e-04 | 8 | 118 | 2 | 22916010 | |
| Pubmed | A proteomic snapshot of the human heat shock protein 90 interactome. | 3.43e-04 | 40 | 118 | 3 | 16263121 | |
| Pubmed | OFD1 CCDC174 PSMB1 TAB3 ARF3 NUP54 NCOR2 SATB1 NFKBIE PRMT1 YY1AP1 STIP1 CHD6 KDM6A | 3.55e-04 | 1429 | 118 | 14 | 35140242 | |
| Pubmed | SLC12A6 MYH9 RBP3 LETM1 EHD3 UBA1 UPF2 SACS HECW2 RTRAF ITSN2 STIP1 PLCL1 DNPEP | 3.60e-04 | 1431 | 118 | 14 | 37142655 | |
| Pubmed | 3.99e-04 | 653 | 118 | 9 | 33742100 | ||
| Pubmed | 4.05e-04 | 9 | 118 | 2 | 31605013 | ||
| Pubmed | The human RNA surveillance factor UPF1 is required for S phase progression and genome stability. | 4.05e-04 | 9 | 118 | 2 | 16488880 | |
| Pubmed | 4.94e-04 | 407 | 118 | 7 | 12693553 | ||
| Pubmed | Recruitment of IkappaBalpha to the hes1 promoter is associated with transcriptional repression. | 5.05e-04 | 10 | 118 | 2 | 15536134 | |
| Pubmed | 5.05e-04 | 10 | 118 | 2 | 10828067 | ||
| Pubmed | 5.05e-04 | 10 | 118 | 2 | 34157123 | ||
| Pubmed | A point mutation in Myh10 causes major defects in heart development and body wall closure. | 5.05e-04 | 10 | 118 | 2 | 24825879 | |
| Pubmed | 5.15e-04 | 538 | 118 | 8 | 28524877 | ||
| Pubmed | 5.54e-04 | 47 | 118 | 3 | 8812413 | ||
| Pubmed | UBA5 MYH9 ZSWIM3 RALGAPB NCAPH2 UBA1 UPF2 SLC15A2 PHLPP1 PRMT1 STIP1 CDC25A SOS1 | 5.83e-04 | 1327 | 118 | 13 | 32694731 | |
| Pubmed | 6.15e-04 | 11 | 118 | 2 | 27912060 | ||
| Pubmed | 6.15e-04 | 11 | 118 | 2 | 19015242 | ||
| Pubmed | 7.12e-04 | 708 | 118 | 9 | 39231216 | ||
| Pubmed | 7.37e-04 | 12 | 118 | 2 | 24399297 | ||
| Pubmed | Generation and comprehensive analysis of an influenza virus polymerase cellular interaction network. | 7.37e-04 | 12 | 118 | 2 | 21994455 | |
| Pubmed | Notch signaling promotes airway mucous metaplasia and inhibits alveolar development. | 7.37e-04 | 12 | 118 | 2 | 19369400 | |
| Pubmed | 7.37e-04 | 12 | 118 | 2 | 30631079 | ||
| Pubmed | 7.37e-04 | 12 | 118 | 2 | 29459437 | ||
| Cytoband | 22q13.33 | 1.31e-04 | 38 | 118 | 3 | 22q13.33 | |
| GeneFamily | Ubiquitin like modifier activating enzymes | 7.09e-04 | 10 | 73 | 2 | 100 | |
| GeneFamily | EF-hand domain containing | 1.92e-03 | 219 | 73 | 5 | 863 | |
| GeneFamily | Phospholipases|C2 domain containing phospholipases | 2.63e-03 | 19 | 73 | 2 | 832 | |
| GeneFamily | Ankyrin repeat domain containing | 2.96e-03 | 242 | 73 | 5 | 403 | |
| Coexpression | GSE4142_GC_BCELL_VS_MEMORY_BCELL_UP | 3.35e-06 | 200 | 117 | 8 | M6397 | |
| Coexpression | GSE25677_MPL_VS_R848_STIM_BCELL_DN | 1.74e-05 | 181 | 117 | 7 | M8187 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.35e-07 | 189 | 118 | 7 | 7ab1cfc1657277858339f7258a0c4ae9cb42fdf8 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.88e-07 | 191 | 118 | 7 | 08042952431ca1a6fd7dfc13f36eb28643979598 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.88e-07 | 191 | 118 | 7 | 7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.17e-07 | 192 | 118 | 7 | 992d08092edbc68c47b945deb8708379738c239a | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.37e-07 | 196 | 118 | 7 | 9830fb3da7a60f65ad463e9054bb77c06b025e4d | |
| ToppCell | control-unassigned|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.04e-06 | 199 | 118 | 7 | 5db7c8089172ac8e796613b3cef618d87007a0ab | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.07e-06 | 200 | 118 | 7 | a3a1e35934d676c39f917652e50c502cb2f613c1 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.07e-06 | 200 | 118 | 7 | c06426f877919bdd267ea2fd7e7973c6619832ae | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_only / Treatment groups by lineage, cell group, cell type | 1.07e-06 | 200 | 118 | 7 | 69edc375d85689300d1dbc1217fedc40063ecdcb | |
| ToppCell | facs-Kidney-nan-3m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.40e-06 | 166 | 118 | 6 | 6a948aefd283a2572da37b59dbc142b6e686b024 | |
| ToppCell | facs-Kidney-nan-3m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.40e-06 | 166 | 118 | 6 | 8d0c4eb90a2c006f96ae61d3d94c96fb64bc0c4d | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.07e-06 | 174 | 118 | 6 | c529f3674b784f872f4387ffdeb46aecb619976b | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.05e-06 | 178 | 118 | 6 | 8ec2a25dda96c9cc9c2904b6cb18f75a293f4969 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.05e-06 | 178 | 118 | 6 | 6c91331196696e0cf239d105f458e3230659fa38 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.72e-06 | 184 | 118 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.72e-06 | 184 | 118 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.72e-06 | 184 | 118 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.72e-06 | 184 | 118 | 6 | 327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.17e-05 | 190 | 118 | 6 | 2de8e4cfeee350a9a76af749d6ce58d948c129b8 | |
| ToppCell | distal-3-Epithelial-Proximal_Ciliated|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.43e-05 | 197 | 118 | 6 | 15b4d1203943ce90a7083178d4a4284d9b323071 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.47e-05 | 198 | 118 | 6 | 22e766df1276c5b14aa0d83f434f47140ebb98ea | |
| ToppCell | control-unassigned|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.52e-05 | 199 | 118 | 6 | 50e2da35edff1aadef939cfbd4549f73c1a07717 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.56e-05 | 200 | 118 | 6 | 786f1ae53e60b5ffbf4bfd393d10b802478148b3 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_3|Control_saline / Treatment groups by lineage, cell group, cell type | 1.56e-05 | 200 | 118 | 6 | b0866b497aa71d06cef25f9a335fa584e95fa7e0 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_2|Control_saline / Treatment groups by lineage, cell group, cell type | 1.56e-05 | 200 | 118 | 6 | bc8949eb34482aca166c4602ff6ab876cb4c2c3c | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.64e-05 | 154 | 118 | 5 | ec920cae12ea1d14b6c973f6e903f895f80e3c50 | |
| ToppCell | Basal_cells-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 6.76e-05 | 160 | 118 | 5 | b223cc47e68a29df4758c5ccf8f6dbffe2a6fa1d | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.60e-05 | 164 | 118 | 5 | e3983f655cdba308fb192182829f17bef99ce0ba | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-9|TCGA-Brain / Sample_Type by Project: Shred V9 | 8.28e-05 | 167 | 118 | 5 | 013971700e80b71e4b8c79b8fff0d8beeac295c3 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.00e-05 | 170 | 118 | 5 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.77e-05 | 173 | 118 | 5 | cb6389536195443633adb06e5f1b7483530773d1 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.09e-04 | 177 | 118 | 5 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-04 | 181 | 118 | 5 | 4df7972f88117108698efd06b124b232f8588981 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.21e-04 | 181 | 118 | 5 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-04 | 181 | 118 | 5 | cbb530566893281289026bfd93adf721decd4ca3 | |
| ToppCell | Club-club-8|World / Class top | 1.24e-04 | 182 | 118 | 5 | 8111d917e588008d947021460ddf8f1e7ae1337a | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.27e-04 | 183 | 118 | 5 | 8a799807fbf24456a9811e0c64068187940a2f71 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 1.34e-04 | 185 | 118 | 5 | 857c7ca8493e91ef1d0078ddafd6082020f9b169 | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-MEC-MEC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.34e-04 | 185 | 118 | 5 | 76304829fcfb5934188933ca20d33bc8c8b0dc91 | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-MEC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.34e-04 | 185 | 118 | 5 | 0595e7ab37eed690f6e3d16a9a4e9a4bce2b89db | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-Alveolar_Mac|normal_Pleural_Fluid / Location, Cell class and cell subclass | 1.37e-04 | 186 | 118 | 5 | 3314def702fe6a5056d0dadbb3a587c5d1a16412 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.37e-04 | 186 | 118 | 5 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.37e-04 | 186 | 118 | 5 | 85787ff207f109ec7e3c0f729ba9bda739c2fdc9 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.37e-04 | 186 | 118 | 5 | a95744b8649096bd7cfc3591a02841fa411085b3 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.41e-04 | 187 | 118 | 5 | dd1d91f101b837bba513f77defa6e6902b2c0570 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.41e-04 | 187 | 118 | 5 | ae90c263f80c36a410150d499e268d198944a3d9 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.41e-04 | 187 | 118 | 5 | 2b1b2c3792d6c9ab69675ce88842bb589414b530 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.44e-04 | 188 | 118 | 5 | b2d68a32314e9b099ed74d974079ad96359d1ae3 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-Airway_Smooth_Muscle|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-04 | 188 | 118 | 5 | 61f010c165826b434ca3d27553d4c9e13d2c0c51 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-bronchial_smooth_muscle_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-04 | 188 | 118 | 5 | 7553ef7de3575af4cf34704b405b551c1af8eb83 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.44e-04 | 188 | 118 | 5 | 505b6b4277d7dea87aee27191d0acca67928b8e6 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-04 | 189 | 118 | 5 | 7fbe855bfdb47d35e040b04a80fe4b729a3764e8 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.48e-04 | 189 | 118 | 5 | 975e7aa3b862a8b07c2ab8426a14f5cc54998aca | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-04 | 189 | 118 | 5 | 06b35abecd29f902cf251fcc1f6ad33db7ab08a2 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.48e-04 | 189 | 118 | 5 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.52e-04 | 190 | 118 | 5 | 73d94fbae92029745989a8712eed8b99fd84c193 | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.55e-04 | 191 | 118 | 5 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.55e-04 | 191 | 118 | 5 | f3158cedf67e3b90aa94ea1f61c72c33aaa2d5ba | |
| ToppCell | facs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-04 | 192 | 118 | 5 | 796e04365b2ea645e14d8970c8c22ff96ddd75de | |
| ToppCell | facs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-04 | 192 | 118 | 5 | 0134967d36b5dac1e4646d1a555ca8bb4eeac8ef | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.63e-04 | 193 | 118 | 5 | 08696a99309f5b088692ddac8cca35413b5e810d | |
| ToppCell | ASK452-Endothelial-Lymphatic|Endothelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.71e-04 | 195 | 118 | 5 | 20f492299a684ac1b7dd1bbc36a533cd6f9a1c93 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.71e-04 | 195 | 118 | 5 | d53585715c7f5827c4f5a6db11cb31857ee9d4f0 | |
| ToppCell | distal-Epithelial-Proximal_Ciliated|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.71e-04 | 195 | 118 | 5 | abe7998421dc59bdae35c0c2251c4a1ebef5e021 | |
| ToppCell | distal-Epithelial-Proximal_Ciliated-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.71e-04 | 195 | 118 | 5 | 0e3f74e0877d33c11f048b9be8394596cf5c9c4c | |
| ToppCell | COVID-19-lung-Pericytes/_Smooth_Muscle|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.75e-04 | 196 | 118 | 5 | 754a3613340932563cd8424d775e18b93c3a1aaa | |
| ToppCell | PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.79e-04 | 197 | 118 | 5 | 383d598ce3f8f5fc98bef3300e4cf7b6992aec9c | |
| ToppCell | PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.79e-04 | 197 | 118 | 5 | 3cc4e56a77f96a43f9b5a24cf1b9524c927ef795 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.79e-04 | 197 | 118 | 5 | 6d0d68d460243a0259ada93ebda40fa7b3088eeb | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.84e-04 | 198 | 118 | 5 | cbb63b255bdc92a557c5db1f08f7766ed9346607 | |
| ToppCell | COVID-19_Moderate-Non-classical_Monocyte|World / disease group, cell group and cell class | 1.84e-04 | 198 | 118 | 5 | 8449934e20bb2a34079fb642cae0d4647b9efe51 | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial-Ciliated|LPS_only / Treatment groups by lineage, cell group, cell type | 1.84e-04 | 198 | 118 | 5 | 6d90b541fde357fbb40f8f7d4e8628a48b679718 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.88e-04 | 199 | 118 | 5 | 26bb93347e6722abd174dfa62cab692ce2b7eb23 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW08-Neuronal-Intermediate|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 1.92e-04 | 200 | 118 | 5 | 401d50fa394fa863fa7836344110ae5c7af3250a | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.92e-04 | 200 | 118 | 5 | b5b5a32925f225610fe25a021a742d6397162863 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.92e-04 | 200 | 118 | 5 | 4e1e19214aeebbdca004de7faaf4cc9d18498591 | |
| ToppCell | Control_saline-Mesenchymal_myocytic|Control_saline / Treatment groups by lineage, cell group, cell type | 1.92e-04 | 200 | 118 | 5 | 5ed4261157cd51109b314818133ac3a0d34ee5fa | |
| ToppCell | Sepsis-Leuk-UTI|Sepsis / Disease, condition lineage and cell class | 1.92e-04 | 200 | 118 | 5 | 7d92b24c0c888dd46e40b7e3c6c2645c3604f132 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.92e-04 | 200 | 118 | 5 | 67dcbd86fbc79fd585d0793f979e4aac100326c9 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte|Control_saline / Treatment groups by lineage, cell group, cell type | 1.92e-04 | 200 | 118 | 5 | cb7ef774b6d300f8019c5b16a04e3ebd165e4f1c | |
| ToppCell | mild-CD163+_Monocytes_(Sample_ID1_d7)|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.92e-04 | 200 | 118 | 5 | 82126e25bfd8fba78dc1348fa5ad6a576289a139 | |
| ToppCell | LPS_only-Mesenchymal_myocytic|LPS_only / Treatment groups by lineage, cell group, cell type | 1.92e-04 | 200 | 118 | 5 | 8bc9923f82bfb836e2f524204c92050edeae8ca5 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_only / Treatment groups by lineage, cell group, cell type | 1.92e-04 | 200 | 118 | 5 | 7c62678cf408aaaf98d6df0fb27814d2007c4521 | |
| Disease | Congenital aneurysm of ascending aorta | 1.56e-05 | 2 | 117 | 2 | C0345050 | |
| Disease | mood instability measurement | 1.61e-04 | 128 | 117 | 5 | EFO_0008475 | |
| Disease | obesity (implicated_via_orthology) | 2.23e-04 | 215 | 117 | 6 | DOID:9970 (implicated_via_orthology) | |
| Disease | mitochondrial metabolism disease (implicated_via_orthology) | 3.62e-04 | 35 | 117 | 3 | DOID:700 (implicated_via_orthology) | |
| Disease | common bile duct neoplasm (is_marker_for) | 4.30e-04 | 8 | 117 | 2 | DOID:4608 (is_marker_for) | |
| Disease | melanoma | 4.77e-04 | 248 | 117 | 6 | C0025202 | |
| Disease | dry eye syndrome (is_marker_for) | 6.87e-04 | 10 | 117 | 2 | DOID:10140 (is_marker_for) | |
| Disease | multiple sclerosis symptom measurement | 8.14e-04 | 46 | 117 | 3 | EFO_0803536 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 9.80e-04 | 49 | 117 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis | 1.17e-03 | 295 | 117 | 6 | EFO_0000384, EFO_0000676, EFO_0000729, EFO_0003898, EFO_0004268 | |
| Disease | gallbladder cancer (is_implicated_in) | 1.18e-03 | 13 | 117 | 2 | DOID:3121 (is_implicated_in) | |
| Disease | 5-methyluridine (ribothymidine) measurement | 1.38e-03 | 14 | 117 | 2 | EFO_0020013 | |
| Disease | Adenocarcinoma of lung (disorder) | 1.41e-03 | 206 | 117 | 5 | C0152013 | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 1.58e-03 | 15 | 117 | 2 | C0496930 | |
| Disease | Benign neoplasm of bladder | 1.58e-03 | 15 | 117 | 2 | C0154017 | |
| Disease | Carcinoma in situ of bladder | 1.58e-03 | 15 | 117 | 2 | C0154091 | |
| Disease | otitis media (biomarker_via_orthology) | 2.04e-03 | 17 | 117 | 2 | DOID:10754 (biomarker_via_orthology) | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipid measurement | 2.23e-03 | 229 | 117 | 5 | EFO_0004639, EFO_0008317 | |
| Disease | Carcinoma of bladder | 2.29e-03 | 18 | 117 | 2 | C0699885 | |
| Disease | cerebral infarction (is_marker_for) | 2.55e-03 | 19 | 117 | 2 | DOID:3526 (is_marker_for) | |
| Disease | intellectual disability (implicated_via_orthology) | 3.33e-03 | 75 | 117 | 3 | DOID:1059 (implicated_via_orthology) | |
| Disease | Kidney Failure | 3.42e-03 | 22 | 117 | 2 | C0035078 | |
| Disease | Sensorineural Hearing Loss (disorder) | 3.73e-03 | 23 | 117 | 2 | C0018784 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QSPFNDLNRQLVNMG | 61 | Q96D05 | |
| LQRNINENFGPNTEM | 181 | Q9ULA0 | |
| KLEDKQPGNMAGNFN | 296 | Q9H5V8 | |
| PSKINLNMDQFLEQA | 506 | Q86UK0 | |
| QDPNINDNLLGNIMA | 961 | Q9P2G1 | |
| LLVFANKQDLPNAMN | 121 | P61204 | |
| FRGLKKEDNQNAMPF | 286 | Q86XS5 | |
| PKNNFAERQKRLQAM | 356 | Q96LY2 | |
| RNAGQLDNFLLQQMP | 736 | Q6DHV5 | |
| GMRPNAKNNRDLDFT | 336 | Q99873 | |
| GRDKNIPAGLQSMNQ | 16 | Q3YEC7 | |
| LNERIKNMQFSNTPD | 561 | Q9NZM3 | |
| NNPFKQENVLARMVA | 591 | O75665 | |
| NGDKARLENMSPRQV | 131 | Q9UPP5 | |
| FLNMFANKQLELPRG | 976 | Q9P2P5 | |
| APLENFNVKNIVNML | 421 | Q86T65 | |
| DADQQRIKFINMNGL | 401 | Q9Y618 | |
| EQMDFRANLQRQVKP | 921 | Q15746 | |
| GANKDMQNNREETPL | 2051 | P46531 | |
| PGFQRNMKNRQCEDL | 3831 | Q9NZR2 | |
| AQQMRFEPDNKNTQR | 191 | Q7Z3D4 | |
| MDKQPANFIVLLNNV | 856 | Q2M2H8 | |
| AQKQRMDIENPNLYG | 186 | Q6ZRS4 | |
| VNPQMLQDLQAAGFD | 101 | O95835 | |
| QMLQAIRKANPGSDF | 221 | Q9Y216 | |
| NNNIKAIPEKAFMGN | 266 | Q9HBX8 | |
| SAGQIDQNFKMPQEI | 141 | Q96IM9 | |
| KNQPLMELLLRNGAD | 381 | O00221 | |
| DNPQLSALLMGKANN | 776 | O15550 | |
| QNNRDAMELKPNGGA | 776 | Q8NCM2 | |
| LEMDQQAGKLAPANG | 626 | O95202 | |
| RNFINDEMQAKGIPQ | 256 | Q96MG8 | |
| EDPAAQKMQLAFRLQ | 1811 | O15031 | |
| FLQLRNLNDNQPMFE | 551 | Q9NYQ8 | |
| LEQGKQQLMPQEAGL | 661 | P54098 | |
| RLIGDAAKNQVAMNP | 51 | P34931 | |
| NTNGRLMANPEALKI | 16 | P32455 | |
| NLQAMKAQFERDLQG | 1561 | P35579 | |
| GLVCRNQDQQGPFKM | 1816 | P98088 | |
| GLVCRNQDQQGPFKM | 4026 | P98088 | |
| QNVFPAKEQFMVQRG | 86 | Q6ZWE6 | |
| KLPFEFMQSGNNEAL | 291 | Q06190 | |
| QEMNRLFGATNPKNF | 736 | Q9BXJ9 | |
| LNAPTQFKGRLNELM | 421 | Q7Z3B4 | |
| LNTMNFDLINGKPFR | 76 | Q96DU9 | |
| GDNPQRALDINKVML | 506 | Q96JP2 | |
| LMDFINQKQRDPRLN | 246 | Q01970 | |
| GNQPQNGRMLVSKDA | 211 | Q8N9I9 | |
| NLLEAFGRRQNKPME | 151 | Q9NWS6 | |
| NSLKEFNLQNMGLPD | 1256 | P04114 | |
| SHQLQKAMPFLQNRG | 816 | Q9Y2F5 | |
| QIFAKMQEANNPRKL | 136 | Q8NA47 | |
| LFIINNFANSDRPMK | 1551 | Q5JSL3 | |
| KEELMQDLQNPGGNR | 166 | Q5T0U0 | |
| PDFQLQAMIQAAGKL | 771 | Q8TD26 | |
| NQNCLKNAGNPRDMR | 196 | Q9BQW3 | |
| LLVFANKQDLPNAMN | 121 | P84077 | |
| RLPMLDAKQLQNEND | 596 | Q5SZL2 | |
| MGNLNLPKPQQIDFA | 226 | O95571 | |
| NRNNQKPDRDGERNM | 346 | Q8NA03 | |
| MDKNLQGRLFISPAN | 186 | Q6PII3 | |
| LLFPENVMQNKDNAL | 826 | Q8NEL9 | |
| APFMKLAQQIQDGSR | 316 | Q9P225 | |
| EGFQDLLNMRPDQSN | 1066 | Q9UHW9 | |
| NRNLGFFVLQPDQMQ | 331 | Q16348 | |
| MQKNLQGLDPKALNN | 101 | Q6AZY7 | |
| FKNSEGKQLDPNEMR | 3861 | Q9NZJ4 | |
| ALKNRQNLFQEEGMI | 481 | Q92736 | |
| EMKPNLDGVDLFNNG | 216 | Q68D86 | |
| AMLQPLLDNQVGFKN | 171 | P20618 | |
| GARLLKPQDLEMQFQ | 351 | Q92523 | |
| QPLEVKNNSNLQRMG | 61 | P30304 | |
| GMEVNQPKFNQRRIS | 856 | Q9HAU5 | |
| KLLLDFAAFPNQMEN | 506 | Q9Y283 | |
| NNPDFKAGVMALANL | 126 | Q9Y224 | |
| ALSQADVNLKMPRNN | 81 | Q9GZN7 | |
| KENNLNRLPKGMQAR | 171 | Q8N4H0 | |
| EKQMIFFLNGNQLPP | 436 | Q96DX4 | |
| PQLKEGLQNMEARLA | 106 | P31948 | |
| DLLQSRGNFDPKAMN | 596 | Q8N5C8 | |
| QELENQMKERQGLFF | 81 | Q9BXJ8 | |
| NGALQPSDLDRNKMK | 351 | Q9Y6E0 | |
| QNRSKMNIPFRIGNA | 296 | Q9Y617 | |
| LQGAENNMSEIQKQP | 226 | Q96T21 | |
| LQMQTQPFRDANLGL | 131 | Q6ZT89 | |
| DIKRFFENLNPMGNS | 986 | Q07889 | |
| EMEKGFNPAQPLNIR | 686 | Q12769 | |
| GDFPNLKRMQDQLQA | 351 | Q9NZN3 | |
| TERNGKPENNTMNIN | 481 | Q01826 | |
| EEFRQVMNGFQNRKP | 86 | P07711 | |
| DEMEKNNNPLYSRQG | 156 | Q6IBW4 | |
| IMNNAAQPDGKIRLA | 546 | Q2KHT3 | |
| KFDPQDMDKNLNAIQ | 386 | Q8IWX7 | |
| KQPLDFMEGNQNTPR | 226 | Q15111 | |
| GMDPLGNRERQNQKE | 361 | A0A0J9YY54 | |
| QNVKGETPLDMALQN | 246 | Q8IUH4 | |
| FPENLLGMQEAIQQA | 41 | P10745 | |
| EPQMKVAALRAGAQQ | 186 | Q8WVN6 | |
| LQESNTPGLRQMNFK | 466 | Q9BW04 | |
| DKVELANMNRLFFQP | 106 | Q9GZZ9 | |
| QENNDLALQPGDRIM | 306 | Q6ZMT1 | |
| LARMENQAFDPEKGN | 271 | Q15035 | |
| NGPMLRLKANDFAQK | 106 | Q8IY51 | |
| FVPNNEALNNMKDGT | 556 | Q8WWQ8 | |
| NFIDLMVRQGNIDNP | 81 | Q9HCJ6 | |
| LAMLEQPLGNEQNDF | 956 | Q86X10 | |
| QGLQPNGEEMTLKQF | 961 | P22314 | |
| GKNFNLNMNFVPLRK | 111 | P51523 | |
| KNLNMNRAPDNIIKF | 326 | Q9H869 | |
| NQLLAEMDGFKPNEG | 461 | Q96TA2 | |
| ESQQENQRMGKGQIP | 196 | Q9UJL9 | |
| NTGQPEKQGRNDMIQ | 606 | Q96MP5 | |
| GNFLQSLPAELENMK | 746 | O60346 | |
| QDGESLQMFQALKRP | 736 | O94901 | |
| NNMKANFGDVVPRRD | 246 | Q2TAA8 | |
| SGAQMPNNIEKNFSR | 291 | Q6PP77 | |
| LKMAGNSFQENFLPD | 476 | O00206 | |
| KRQEPLMVQANADGR | 41 | P50607 | |
| EPKFNLMQILQDNGN | 656 | Q6EMB2 | |
| RNPMNALNVGKLLDI | 256 | B1APH4 | |
| ELPQFIQAKVNALNM | 1521 | P20929 |